iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sun Pharmaceuticals Industries Ltd Option Chain

1,676.3
(-0.20%)
Jul 4, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,400₹0.7 0%36,7500%
--1,440₹0.55 -8.33%48,6502.96%
00%₹215.3 0%1,480₹1.15 -4.16%2,36,9500%
7000%₹169.15 0%1,500₹2.1 20%4,63,750-3.14%
--1,520₹2.95 15.68%45,1508.40%
--1,540₹4.15 12.16%2,89,45011.60%
7000%₹118.65 -0.5%1,560₹5.55 11%1,31,95040.14%
1,0500%₹107.9 -0.41%1,580₹7.9 19.69%76,3000%
56,700-7.95%₹89.75 -0.82%1,600₹10.8 14.28%2,98,90013.71%
60,2005.52%₹76.35 3.31%1,620₹14.8 10.86%1,28,4501.66%
82,950-6.32%₹59.85 1.26%1,640₹20.45 12.67%1,81,650-12.33%
1,50,50014.97%₹46.9 1.95%1,660₹27.9 10.71%2,48,150-0.28%
5,72,9501.74%₹35.85 3.61%1,680₹36.5 7.66%2,49,200-2.06%
16,18,750-1.23%₹26.2 6.28%1,700₹46.1 4.65%2,27,5004.16%
11,33,6503.05%₹18.6 8.77%1,720₹58.35 3.64%1,31,95016%
6,66,40031.40%₹13.1 11.96%1,740₹73 3.54%62,6505.29%
4,69,35012.87%₹9 11.8%1,760₹88.1 0%21,7000%
2,12,10012.84%₹6.3 13.51%1,780₹103.35 -0.33%20,300-1.69%
5,44,95013.73%₹4.4 15.78%1,800₹124.55 1.17%1,20,050-3.10%
1,19,35046.98%₹3.15 23.52%1,820--
2,68,100-1.41%₹2 25%1,840--
66,5001.06%₹1.4 12%1,860--
2,89,8000%₹0.95 26.66%1,880₹220 0%1,4000%
38,5000%₹0.6 0%1,920--

Sun Pharma.Inds.: Related NEWS

Top Stocks for Today - 16th June 2025
16 Jun 2025|06:23 AM

Here are some of the stocks that may see significant price movement today: Sun Pharma, Vedanta, SpiceJet, etc.

Read More
US FDA Flags 8 Observations at Sun Pharma’s Halol Facility After GMP Inspection
15 Jun 2025|11:50 PM

The visit lasted from June 2 to June 13 and focused on checking for compliance with Good Manufacturing Practices.

Read More
Sun Pharma Expands Specialty Drug Pipeline with $25 Million Pharmazz Deal
24 May 2025|07:51 PM

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

Read More
Sun Pharma Q4 FY25 Revenue Rises 8.5% to ₹12,816 Crore
23 May 2025|12:07 PM

The Board recommended a final dividend of ₹5.50 per share for FY25.

Read More
Top Stocks for Today - 7th May 2025
7 May 2025|08:06 AM

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis
26 Apr 2025|01:15 PM

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million
10 Mar 2025|10:46 AM

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend
31 Jan 2025|10:17 PM

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Sun Pharma's Hair Loss Drug Approved by USFDA
26 Jul 2024|01:45 PM

The US Food and Drug Administration (USFDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets, according to a regulatory filing.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.